Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

This FDA vote was personal

Committee member who recommended biosimilar had own experience with costly drugs.

Talk about first hand knowledge.

The Washington Post's Wonkblog recently profiled Randy Hillard.

The Michigan State University psychiatry professor was diagnosed with stage four stomach cancer in 2010, and given less than a year to live.

But, for four years a once-every-three-weeks infusion of Herceptin, a breast cancer drug approved to treat some types of stomach cancer, has kept in him alive – at the tune of $1 million, with about $100,000 of it being paid for himself.

“I can barely afford that, and I’m a doctor,” he told them.

Hillard, however, is also a member of the FDA committee that recently recommended approval of the what could be the U.S' first biosimilar. Biosimilars are basically generic versions of biologics.

“Really, truly, we are betting our lives on these new biosimilars,” Hillard said.

As the blog post points out, the U.S. has had generic versions of drugs for years, making the cost to consumers lower. But, if the FDA takes the committees recommendation and approves the country's first biosimilar, it will open up a whole new category of lower-cost drugs to patients.

Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report